TIMP1 represses sorafenib-triggered ferroptosis in colorectal cancer cells by activating the PI3K/Akt signaling pathway

References

• Patel SG, Boland CR. Colorectal cancer in persons under age 50: seeking causes and solutions. Gastrointest Endosc Clin N Am. 2020;30(3):441–455.
   PubMedGoogle Scholar
• Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–685.
   PubMed Web of Science ®Google Scholar
• Martchenko K, Schmidtmann I, Thomaidis T, et al. Last line therapy with sorafenib in colorectal cancer: a retrospective analysis. World J Gastroenterol. 2016;22(23):5400–5405.
   PubMed Web of Science ®Google Scholar
• Jeong KY, Park M, Sim JJ, et al. Combination antitumor effect of sorafenib via calcium-dependent deactivation of focal adhesion kinase targeting colorectal cancer cells. Molecules. 2020;25(22):5299.
   PubMed Web of Science ®Google Scholar
• Liang C, Zhang X, Yang M, et al. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31(51):e1904197.
   PubMed Web of Science ®Google Scholar
• Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88.
   PubMed Web of Science ®Google Scholar
• Chen X, Kang R, Kroemer G, et al. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280–296.
   PubMed Web of Science ®Google Scholar
• Chen X, Yu C, Kang R, et al. Cellular degradation systems in ferroptosis. Cell Death Differ. 2021;28(4):1135–1148.
   PubMed Web of Science ®Google Scholar
• Sun X, Niu X, Chen R, et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology. 2016;64(2):488–500.
   PubMed Web of Science ®Google Scholar
• Li ZJ, Dai HQ, Huang XW, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301–310.
   PubMed Web of Science ®Google Scholar
• Schoeps B, Eckfeld C, Prokopchuk O, et al. TIMP1 triggers neutrophil extracellular trap formation in pancreatic cancer. Cancer Res. 2021;81(13):3568–3579.
   PubMed Web of Science ®Google Scholar
• Yang L, Jiang Q, Li DZ, et al. TIMP1 mRNA in tumor-educated platelets is diagnostic biomarker for colorectal cancer. Aging. 2019;11(20):8998–9012.
   PubMedGoogle Scholar
• Song G, Xu S, Zhang H, et al. TIMP1 is a prognostic marker for the progression and metastasis of Colon cancer through FAK-PI3K/AKT and MAPK pathway. J Exp Clin Cancer Res. 2016;35(1):148.
   PubMed Web of Science ®Google Scholar
• Yi J, Zhu J, Wu J, et al. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117(49):31189–31197.
   PubMed Web of Science ®Google Scholar
• Liu H, Xiang Y, Zong QB, et al. miR-6745-TIMP1 axis inhibits cell growth and metastasis in gastric cancer. Aging (Albany NY). 2021;13(21):24402–24416.
   PubMedGoogle Scholar
• Hermann CD, Schoeps B, Eckfeld C, et al. TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer. J Exp Med. 2021;218(11):e20210911.
   PubMed Web of Science ®Google Scholar
• Balkhi S, Mashayekhi F, Salehzadeh A, et al. TIMP1 and TIMP3 circulating levels and promoter polymorphisms in breast cancer. Br J Biomed Sci. 2021;78(4):236–238.
   PubMed Web of Science ®Google Scholar
• Li H, Liu J, Xiao X, et al. A novel aptamer LL4A specifically targets vemurafenib-resistant melanoma through binding to the CD63 protein. Mol Ther Nucleic Acids. 2019;18:727–738.
   PubMedGoogle Scholar
• D'Costa Z, Jones K, Azad A, et al. Gemcitabine-induced TIMP1 attenuates therapy response and promotes tumor growth and liver metastasis in pancreatic cancer. Cancer Res. 2017;77(21):5952–5962.
   PubMed Web of Science ®Google Scholar
• Li B, Wei S, Yang L, et al. CISD2 promotes resistance to sorafenib- induced ferroptosis by regulating autophagy in hepatocellular carcinoma. Front Oncol. 2021;11:657723.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shen Z, Zhao S, et al. Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/akt/Nrf2 pathway: a network pharmacology approach. Ecotoxicol Environ Saf. 2022;239:113615.
   PubMed Web of Science ®Google Scholar
• Yosef HK, Frick T, Hammoud MK, et al. Exploring the efficacy and cellular uptake of sorafenib in Colon cancer cells by raman micro-spectroscopy. Analyst. 2018;143(24):6069–6078.
   PubMed Web of Science ®Google Scholar
• Qin Y. Identification of prognosis-associated biomarkers in thyroid carcinoma by a bioinformatics analysis. Int J Gen Med. 2021;14:5737–5747.
   PubMed Web of Science ®Google Scholar
• Böckelman C, Beilmann-Lehtonen I, Kaprio T, et al. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer. BMC Cancer. 2018;18(1):679.
   PubMedGoogle Scholar
• Chen L, Lu D, Sun K, et al. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Gene. 2019;692:119–125.
   PubMed Web of Science ®Google Scholar
• Tan Y, Li X, Tian Z, et al. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Biochem Pharmacol. 2021;189:114085.
   PubMed Web of Science ®Google Scholar
• Korpi JT, Hagström J, Lehtonen N, et al. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg Oncol. 2011;20(1):e18-22–e22.
   PubMed Web of Science ®Google Scholar
• Guccini I, Revandkar A, D'Ambrosio M, et al. Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis. Cancer Cell. 2021;39(1):68–82.e9.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266–282.
   PubMed Web of Science ®Google Scholar
• Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144–152.
   PubMed Web of Science ®Google Scholar
• Sun T, Chi JT. Regulation of ferroptosis in cancer cells by Yap/TAZ and hippo pathways: the therapeutic implications. Genes Dis. 2021;8(3):241–249.
   PubMed Web of Science ®Google Scholar
• Yu Y, Xie Y, Cao L, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2(4):e1054549.
   PubMed Web of Science ®Google Scholar
• Fresno Vara JA, Casado E, de Castro J, et al. PI3K/akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193–204.
   PubMed Web of Science ®Google Scholar